CAMERON DERBYSHIRE: Open Payments
NPI 1609130269 · SPRINGFIELD, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$888 in 20 payments from 8 companies in 2025. Trend: 2023 $59 · 2024 $131 · 2025 $888
Food & beverage: $853Education: $35
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 9 | $272 |
| TOLMAR, INC. | 4 | $203 |
| Endo USA, Inc. | 1 | $174 |
| UROGEN PHARMA, INC. | 1 | $117 |
| Ferring Pharmaceuticals Inc. | 2 | $49 |
| AstraZeneca Pharmaceuticals LP | 1 | $35 |
| Caris MPI, Inc. | 1 | $24 |
| Boston Scientific Corporation | 1 | $14 |
Products named: ERLEADA, XIAFLEX, ADSTILADRIN, IMFINZI, RUBRACA, MI CANCER SEEK, ELIGARD, AMS 700.
Industry payments across OR — which companies pay providers there.
